Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2018

01-10-2018

Effects of cupric chloride on coagulation in human plasma: role of fibrinogen

Authors: Vance G. Nielsen, Timothy D. Ward, Paul M. Ford

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2018

Login to get access

Abstract

Introduction

Copper poisoning is associated with severe multiorgan injury and potentially death if chelation therapy is not administered. Of interest, while important gastrointestinal and urinary tract hemorrhage is associated with copper poisoning, very little is known concerning the nature of copper induced coagulopathy.

Methods

Using thrombelastography, we assessed changes in coagulation kinetics in human plasma following exposure to copper concentrations encountered during poisoning.

Results

While time to commence coagulation was not compromised, both velocity of thrombus growth and final strength were diminished. This result was duplicated with one concentration of copper in factor XIII deficient plasma. This pattern of coagulation kinetic response was interpreted as copper mediated fibrinogen dysfunction, perhaps via oxidation of key fibrinogen disulfide bridges. Lastly, experiments wherein glutathione was added implicated copper generated radical oxygen species as one of the mechanisms responsible for compromised coagulation kinetics.

Conclusions

While chelation therapy is the key to survival following copper poisoning, perhaps this and future investigations of how copper affects coagulation may provide insight into effective supportive therapy for patients with active bleeding.
Literature
2.
go back to reference Naha K, Saravu K, Shastry BA (2012) Blue vitriol poisoning: a 10-year experience in a tertiary care hospital. Clin Toxicol (Phila) 50:197–201CrossRef Naha K, Saravu K, Shastry BA (2012) Blue vitriol poisoning: a 10-year experience in a tertiary care hospital. Clin Toxicol (Phila) 50:197–201CrossRef
3.
go back to reference Jantsch W, Kulig K, Rumack BH (1984) Massive copper sulfate ingestion resulting in hepatotoxicity. J Toxicol Clin Toxicol 22:585–588CrossRefPubMed Jantsch W, Kulig K, Rumack BH (1984) Massive copper sulfate ingestion resulting in hepatotoxicity. J Toxicol Clin Toxicol 22:585–588CrossRefPubMed
4.
go back to reference Walsh FM, Crosson FJ, Bayley M, McReynolds J, Pearson BJ (1977) Acute copper intoxication. Pathophysiology and therapy with a case report. Am J Dis Child 131:149–151CrossRefPubMed Walsh FM, Crosson FJ, Bayley M, McReynolds J, Pearson BJ (1977) Acute copper intoxication. Pathophysiology and therapy with a case report. Am J Dis Child 131:149–151CrossRefPubMed
5.
go back to reference Lamont DL, Duflou JA (1988) Copper sulfate. Not a harmless chemical. Am J Forensic Med Pathol 9:226–227CrossRefPubMed Lamont DL, Duflou JA (1988) Copper sulfate. Not a harmless chemical. Am J Forensic Med Pathol 9:226–227CrossRefPubMed
7.
go back to reference Sinkovic A, Strdin A, Svensek (2008) Severe acute copper sulphate poisoning: a case report. Arh Hig Rada Toksikol 59:31–35CrossRefPubMed Sinkovic A, Strdin A, Svensek (2008) Severe acute copper sulphate poisoning: a case report. Arh Hig Rada Toksikol 59:31–35CrossRefPubMed
8.
go back to reference Franchitto N, Gandia-Mailly P, Georges B, Galinier A, Telmon N, Ducassé JL, Rougé D (2008) Acute copper sulphate poisoning: a case report and literature review. Resuscitation 78:92–96CrossRefPubMed Franchitto N, Gandia-Mailly P, Georges B, Galinier A, Telmon N, Ducassé JL, Rougé D (2008) Acute copper sulphate poisoning: a case report and literature review. Resuscitation 78:92–96CrossRefPubMed
9.
go back to reference Nielsen VG, Gurley WQ Jr, Burch TM (2004) The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 99:120–123CrossRefPubMed Nielsen VG, Gurley WQ Jr, Burch TM (2004) The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 99:120–123CrossRefPubMed
10.
go back to reference Nielsen VG, Malayaman SN, Khan ES, Kirklin JK, George JF (2010) Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity. Blood Coagul Fibrinolysis 21:349–353CrossRefPubMed Nielsen VG, Malayaman SN, Khan ES, Kirklin JK, George JF (2010) Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity. Blood Coagul Fibrinolysis 21:349–353CrossRefPubMed
11.
go back to reference Nielsen VG, Audu P, Cankovic L, Lyerly RT 3rd, Steenwyk BL, Armstead V, Powell G (2007) Qualitative thrombelastographic detection of tissue factor in human plasma. Anesth Analg 104:59–64CrossRefPubMed Nielsen VG, Audu P, Cankovic L, Lyerly RT 3rd, Steenwyk BL, Armstead V, Powell G (2007) Qualitative thrombelastographic detection of tissue factor in human plasma. Anesth Analg 104:59–64CrossRefPubMed
12.
go back to reference Lumb I, Hundal MS, Hundal G (2014) Copper(II)-catalyzed disulfide scission–stepwise aerobic oxidative cleavage to sulfinate and sulfonate and reductive anaerobic cleavage to thiols. Inorg Chem 53:7770–7779CrossRefPubMed Lumb I, Hundal MS, Hundal G (2014) Copper(II)-catalyzed disulfide scission–stepwise aerobic oxidative cleavage to sulfinate and sulfonate and reductive anaerobic cleavage to thiols. Inorg Chem 53:7770–7779CrossRefPubMed
13.
go back to reference Zhou P, Zhang J, Zhang T, Liu Y, Juan Liang J, Liua B, Zhanga W (2016) Generation of hydrogen peroxide and hydroxyl radical resulting from oxygen-dependent oxidation of L-ascorbic acid via copper redox-catalyzed reactions. RSC Adv 6:38541–38547CrossRef Zhou P, Zhang J, Zhang T, Liu Y, Juan Liang J, Liua B, Zhanga W (2016) Generation of hydrogen peroxide and hydroxyl radical resulting from oxygen-dependent oxidation of L-ascorbic acid via copper redox-catalyzed reactions. RSC Adv 6:38541–38547CrossRef
14.
go back to reference Olinescu RM1, Kummerow FA (2001) Fibrinogen is an efficient antioxidant. J Nutr Biochem 2:162–169CrossRef Olinescu RM1, Kummerow FA (2001) Fibrinogen is an efficient antioxidant. J Nutr Biochem 2:162–169CrossRef
15.
go back to reference Kaplan IV, Attaelmannan M, Levinson SS (2001) Fibrinogen is an antioxidant that protects beta-lipoproteins at physiological concentrations in a cell free system. Atherosclerosis 158:455–463CrossRefPubMed Kaplan IV, Attaelmannan M, Levinson SS (2001) Fibrinogen is an antioxidant that protects beta-lipoproteins at physiological concentrations in a cell free system. Atherosclerosis 158:455–463CrossRefPubMed
16.
go back to reference Henschen A (1978) Disulfide bridges in the middle part of human fibrinogen. Hoppe Seylers Z Physiol Chem 359:1757–1770CrossRefPubMed Henschen A (1978) Disulfide bridges in the middle part of human fibrinogen. Hoppe Seylers Z Physiol Chem 359:1757–1770CrossRefPubMed
17.
18.
go back to reference Freedman JH, Ciriolo MR, Peisach J (1989) The role of glutathione in copper metabolism and toxicity. J Biol Chem 264:5598–55605PubMed Freedman JH, Ciriolo MR, Peisach J (1989) The role of glutathione in copper metabolism and toxicity. J Biol Chem 264:5598–55605PubMed
19.
go back to reference Milne L, Nicotera P, Orrenius S, Burkitt MJ (1993) Effects of glutathione and chelating agents on copper-mediated DNA oxidation: pro-oxidant and antioxidant properties of glutathione. Arch Biochem Biophys 304:102–109CrossRefPubMed Milne L, Nicotera P, Orrenius S, Burkitt MJ (1993) Effects of glutathione and chelating agents on copper-mediated DNA oxidation: pro-oxidant and antioxidant properties of glutathione. Arch Biochem Biophys 304:102–109CrossRefPubMed
20.
go back to reference Takashima M, Shichiri M, Hagihara Y, Yoshida Y, Niki E (2012) Reactivity toward oxygen radicals and antioxidant action of thiol compounds. Biofactors 38:240–248CrossRefPubMed Takashima M, Shichiri M, Hagihara Y, Yoshida Y, Niki E (2012) Reactivity toward oxygen radicals and antioxidant action of thiol compounds. Biofactors 38:240–248CrossRefPubMed
21.
go back to reference Speisky H, Gómez M, Burgos-Bravo F, López-Alarcón C, Jullian C, Olea-Azar C, Aliaga ME (2009) Generation of superoxide radicals by copper-glutathione complexes: redox-consequences associated with their interaction with reduced glutathione. Bioorg Med Chem 17:1803–1810CrossRefPubMed Speisky H, Gómez M, Burgos-Bravo F, López-Alarcón C, Jullian C, Olea-Azar C, Aliaga ME (2009) Generation of superoxide radicals by copper-glutathione complexes: redox-consequences associated with their interaction with reduced glutathione. Bioorg Med Chem 17:1803–1810CrossRefPubMed
22.
go back to reference Aliaga ME, López-Alarcón C, Bridi R, Speisky H (2016) Redox-implications associated with the formation of complexes between copper ions and reduced or oxidized glutathione. J Inorg Biochem 154:78–88CrossRefPubMed Aliaga ME, López-Alarcón C, Bridi R, Speisky H (2016) Redox-implications associated with the formation of complexes between copper ions and reduced or oxidized glutathione. J Inorg Biochem 154:78–88CrossRefPubMed
23.
go back to reference Komáromi I, Bagoly Z, Muszbek L (2011) Factor XIII: novel structural and functional aspects. J Thromb Haemost 9:9–20CrossRefPubMed Komáromi I, Bagoly Z, Muszbek L (2011) Factor XIII: novel structural and functional aspects. J Thromb Haemost 9:9–20CrossRefPubMed
Metadata
Title
Effects of cupric chloride on coagulation in human plasma: role of fibrinogen
Authors
Vance G. Nielsen
Timothy D. Ward
Paul M. Ford
Publication date
01-10-2018
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1704-4

Other articles of this Issue 3/2018

Journal of Thrombosis and Thrombolysis 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.